Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974
Probiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478
Rayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476
Oláh, A., Belágyi, T., Issekutz, Á., Gamal, M. E., & Bengmark, S. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02189.x · Cited by 475
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · cited 1×
“boulardii [29–50].”
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 1×
“blood appeared identical to the probiotic strain LGG by pulse field gel electrophoresis [69]; however, in a subsequent study, the LGG-like isolates from the blood cultures were found to be phenotypically different from probiotic LGG [70] when subject-”
BackgroundSalminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342912 · Cited by 419
Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants
Szajewska, H., Kotowska, M., Mrukowicz, J. Z., Arma′nska, M., & Mikolajczyk, W. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111321 · Cited by 409
Johnston, B. C., Ma, S. S. Y., Goldenberg, J. Z., Thorlund, K., Vandvik, P. O., Loeb, M., & Guyatt, G. H. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00563 · Cited by 367
Bousvaros, A., Guandalini, S., Baldassano, R. N., Botelho, C., Evans, J., Ferry, G. D., Goldin, B., Hartigan, L., Kugathasan, S., Levy, J., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000175905.00212.2c · Cited by 363
Liver Abscess Due to a Lactobacillus rhamnosus Strain Indistinguishable from L. rhamnosus Strain GG
Rautio, M., Jousimies‐Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S., & Koskela, M. (1999) · Clinical Infectious Diseases · doi:10.1086/514766 · Cited by 327
Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome
Kunz, A. N., Noel, J. M., & Fairchok, M. P. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200404000-00017 · Cited by 319
Gao, X. W., Mubasher, M., Fang, C. Y., Reifer, C., & Miller, L. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.11 · Cited by 318
Manzoni, P., Mostert, M., Leonessa, M. L., Priolo, C., Farina, D., Monetti, C., Latino, M. A., & Gomirato, G. (2006) · Clinical Infectious Diseases · doi:10.1086/504324 · Cited by 305
De Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P., & Pace, N. R. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154588.79356.e6 · Cited by 284
Lactobacillus endocarditis caused by a probiotic organism
Mackay, A. D., Taylor, M. B., Kibbler, C. C., & Hamilton-Miller, J. M. T. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00144.x · Cited by 264
Gevers, D., Danielsen, M., Huys, G., & Swings, J. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.2.1270-1275.2003 · Cited by 258
Possible Role of Catheters in Saccharomyces boulardii Fungemia
Hennequin, C., Kauffmann-Lacroix, C., Jobert, A., Viard, J. P., Ricour, C., Jacquemin, J. L., & Berche, P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050003 · Cited by 253
D-Lactic Acidosis in a Man with the Short-Bowel Syndrome
Oh, M. S., Phelps, K. R., Traube, M., Barbosa-Saldivar, J. L., Boxhill, C., & Carroll, H. J. (1979) · New England Journal of Medicine · doi:10.1056/nejm197908023010505 · Cited by 253
Safety of probiotics used to reduce risk and prevent or treat disease.
(2011) · PubMed Central · Cited by 242
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients
Lherm, T., Monet, C., Nougière, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., & Malbrunot, C. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1267-9 · Cited by 238
Mohan, R., Koebnick, C., Schildt, J., Schmidt, S., Mueller, M., Possner, M., Radke, M., & Blaut, M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00767-06 · Cited by 229
Oláh, A., Belágyi, T., Pótó, L., Romics, L., & Bengmark, S. (2007) · PubMed · Cited by 223
Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., & Kuitunen, M. (2008) · Pediatrics · doi:10.1542/peds.2007-1192 · Cited by 219
Bacterial Probiotic Modulation of Dendritic Cells
Drakes, M., Blanchard, T., & Czinn, S. (2004) · Infection and Immunity · doi:10.1128/iai.72.6.3299-3309.2004 · Cited by 218
Rougé, C., Piloquet, H., Butel, M.-J., Berger, B., Rochat, F., Ferraris, L., Des Robert, C., Legrand, A., de la Cochetière, M.-F., N’Guyen, J.-M., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26919 · Cited by 215
Jain, P. K., McNaught, C. E., Anderson, A. D. G., MacFie, J., & Mitchell, C. J. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2003.12.002 · Cited by 212
Veckman, V., Miettinen, M., Pirhonen, J., Sirén, J., Matikainen, S., & Julkunen, I. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003461 · Cited by 185
Recurrent Septicemia in an Immunocompromised Patient Due to Probiotic Strains of Bacillus subtilis
Oggioni, M. R., Pozzi, G., Valensin, P. E., Galieni, P., & Bigazzi, C. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.325-326.1998 · Cited by 178
Ohishi, A., Takahashi, S., Ito, Y., Ohishi, Y., Tsukamoto, K., Nanba, Y., Ito, N., Kakiuchi, S., Saitoh, A., Morotomi, M., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.11.041 · Cited by 170
Riquelme, A. J., Calvo, M. A., Guzmán, A. M., Depix, M. S., García, P., Pérez, C., Arrese, M., & Labarca, J. A. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200301000-00013 · Cited by 166
Mohan, R., Koebnick, C., Schildt, J., Mueller, M., Radke, M., & Blaut, M. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318181b7fa · Cited by 165
Vahabnezhad, E., Mochon, A. B., Wozniak, L. J., & Ziring, D. A. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318279abf0 · Cited by 156 · cited 1×
“tobacillus acidophilus, Lactobacillus casei, and Lactobacillus GG [51–56].”
BackgroundTynkkynen, S., Singh, K. V., & Varmanen, P. (1998) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(98)00051-8 · Cited by 153
Klein, G., Hallmann, C., Casas, I. A., Abad, J., Louwers, J., & Reuter, G. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.01187.x · Cited by 150
Olivares, M., Castillejo, G., Varea, V., & Sanz, Y. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514000609 · Cited by 149
Probiotic treatment of vancomycin‐resistant enterococci: a randomised controlled trial
Manley, K. J., Fraenkel, M. B., Mayall, B. C., & Power, D. A. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb00995.x · Cited by 147
Tannock, G. W., Luchansky, J. B., Miller, L. A., Connell, H., Thode-Andersen, S., Mercer, A. A., & Klaenhammer, T. R. (1994) · Plasmid · doi:10.1006/plas.1994.1007 · Cited by 143
Immunological effects of probiotics with special reference to lactobacilli
Vaarala, O. (2003) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2003.01835.x · Cited by 139
Honeycutt, T. C. B., El Khashab, M., Wardrop, R. M., McNeal-Trice, K., Honeycutt, A. L. B., Christy, C. G., Mistry, K., Harris, B. D., Meliones, J. N., & Kocis, K. C. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000282176.41134.e6 · Cited by 133
Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii
Cesaro, S., Chinello, P., Rossi, L., & Zanesco, L. (2000) · Supportive Care in Cancer · doi:10.1007/s005200000123 · Cited by 109
Nosocomial bacteremia caused byBacillus species
Richard, V., Auwera, P., Snoeck, R., DANEAU, D., & Meunier, F. (1988) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975049 · Cited by 106
Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii
Bassetti, S., Frei, R., & Zimmerli, W. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00133-8 · Cited by 103
Perapoch, J., Planes, A. M., Querol, A., L�pez, V. N., Mart�nez-Benday�n, I., Tormo, R., Fern�ndez, F., Peguero, G., & Salcedo, S. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000295 · Cited by 102
Fungemia with Saccharomyces boulardii in a 1‐Year‐Old Girl with Protracted Diarrhea
Pletincx, M., Legein, J., & Vandenplas, Y. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1995.tb11747.x · Cited by 102
Lin, C., Fung, Z.-F., Wu, C. H. H., & Chung, T. (1996) · Plasmid · doi:10.1006/plas.1996.0039 · Cited by 100
Weizman, Z., & Alsheikh, A. (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719554 · Cited by 98
Endocarditis by Lactobacillus rhamnosus due to Yogurt Ingestion?
Elisabeth Presterl, W. K. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540110026953 · Cited by 84
LeDoux, D., LaBombardi, V. J., & Karter, D. (2006) · International Journal of STD & AIDS · doi:10.1258/095646206776253507 · Cited by 81
Braat, H., de Jong, E. C., van den Brande, J. M. H., Kapsenberg, M. L., Peppelenbosch, M. P., van Tol, E. A. F., & van Deventer, S. J. H. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0509-9 · Cited by 79
A case of D-lactic acid encephalopathy associated with use of probiotics
Munakata, S., Arakawa, C., Kohira, R., Fujita, Y., Fuchigami, T., & Mugishima, H. (2010) · Brain and Development · doi:10.1016/j.braindev.2009.09.024 · Cited by 78
Are live saccharom yces yeasts harmful to patients?
Piarroux, R., Millon, L., Bardonnet, K., Vagner, O., & Koenig, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02001-2 · Cited by 77
[Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS].
Saint-Marc, T., Rossello-Prats, L., & Jl, T. (1991) · PubMed · Cited by 75
Fungemia Due to Saccharomyces Species in a Patient Treated with Enteral Saccharomyces boulardii
Niault, M., Thomas, F., Prost, J., Ansari, F. H., & Kalfon, P. (1999) · Clinical Infectious Diseases · doi:10.1086/517255 · Cited by 72
Bernardo, W. M., Aires, F. T., Carneiro, R. M., Sá, F. P. D., Rullo, V. E. V., & Burns, D. A. (2013) · Jornal de Pediatria · doi:10.1016/j.jped.2013.02.004 · Cited by 72
In vivo transfer of pAMβ1 from Lactobacillus reuteri to Enterococcus faecalis
Morelli, L., Sarra, P. G., & Bottazzi, V. (1988) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1988.tb01905.x · Cited by 71
Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin
Nikolaos, L., Dimitrios, V., Hellen, M., Sofia, K., Aristea, V., Charis, T., Chronis, T., Angellos, P., & Ioannis, P. (2008) · Critical Care · doi:10.1186/cc6843 · Cited by 70
Probiotic lactobacilli and bacteraemia in Stockholm
Sullivan, Å., & Erik Nord, C. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500449826 · Cited by 67
Bacteremic Infection With Pediococcus: Vancomycin-Resistant Opportunist
Barton, L. L., Rider, E. D., & Coen, R. W. (2001) · Pediatrics · doi:10.1542/peds.107.4.775 · Cited by 64 · cited 1×
“tobacillus acidophilus, Lactobacillus casei, and Lactobacillus GG [51–56].”
BackgroundRijnders, B. J. A., Wijngaerden, E. V., Verwaest, C., & Peetermans, W. E. (2000) · Intensive Care Medicine · doi:10.1007/s001340051261 · Cited by 63
Three-Combination Probiotics Therapy in Children With Salmonella and Rotavirus Gastroenteritis
Huang, Y.-F., Liu, P.-Y., Chen, Y.-Y., Nong, B.-R., Huang, I.-F., Hsieh, K.-S., & Chen, K.-T. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31828f1c6e · Cited by 57
Boyle, R. J., Mah, L., Chen, A., Kivivuori, S., Robins‐Browne, R. M., & Tang, M. L. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03100.x · Cited by 52
Saccharomyces boulardii Fungemia in a Patient Receiving Ultra‐levure Therapy
Fredenucci, I., Chomarat, M., Boucaud, C., & Flandrois, J. P. (1998) · Clinical Infectious Diseases · doi:10.1086/517685 · Cited by 51
Santino, I., Alari, A., Bono, S., Teti, E., Marangi, M., Bernardini, A., Magrini, L., Di Somma, S., & Teggi, A. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700120 · Cited by 49
SACCHAROMYCES CEREVISIAE FUNGEMIA IN AN ELDERLY PATIENT WITH CLOSTRIDIUM DIFFICILE COLITIS
Cherifi, S., Robberecht, J., & Miendje, Y. (2004) · Acta Clinica Belgica · doi:10.1179/acb.2004.033 · Cited by 49
Fungämie nach oraler Gabe von Saccharomyces boulardii bei einem multimorbiden Patienten
(2003) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2003-44948 · Cited by 47
Fongémie à Saccharomyces boulardii chez un brûlé grave
Viggiano, M., Badetti, C., Bernini, V., Garabedian, M., & Manelli, J. C. (1995) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(05)80603-3 · Cited by 45
Tommasi, C., Equitani, F., Masala, M., Ballardini, M., Favaro, M., Meledandri, M., Fontana, C., Narciso, P., & Nicastri, E. (2008) · Journal of Medical Case Reports · doi:10.1186/1752-1947-2-315 · Cited by 45
Ouwehand, A. C., Saxelins, M., & Salminen, S. (2004) · Clinical Infectious Diseases · doi:10.1086/425741 · Cited by 44 · cited 6×
“blood appeared identical to the probiotic strain LGG by pulse field gel electrophoresis [69]; however, in a subsequent study, the LGG-like isolates from the blood cultures were found to be phenotypically different from probiotic LGG [70] when subject-”
BackgroundInfluentialProbiotics Provoked D-lactic Acidosis in Short Bowel Syndrome: Case Report and Literature Review
Ku, W., Lau, D., & Huen, K. (2006) · Cited by 42
Ahmed, J., Reddy, B. S., Mølbak, L., Leser, T. D., & MacFie, J. (2013) · International Journal of Surgery · doi:10.1016/j.ijsu.2013.08.019 · Cited by 41
[Saccharomyces boulardii fungemia. Apropos of a case].
Zunic, P., Lacotte, J., Pegoix, M., Buteux, G., Leroy, G., Mosquet, B., & Moulin, M. (1991) · PubMed · Cited by 41
Pellino, G., Sciaudone, G., Candilio, G., Camerlingo, A., Marcellinaro, R., Fatico, S. D., Rocco, F., Canonico, S., Riegler, G., & Selvaggi, F. (2013) · BMC Surgery · doi:10.1186/1471-2482-13-s2-s57 · Cited by 40
Maziade, P.-J., Andriessen, J. A., Pereira, P., Currie, B., & Goldstein, E. J. C. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.833501 · Cited by 40
Burkhardt, O., Köhnlein, T., Pletz, M. W., & Welte, T. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510026454 · Cited by 37
Henry, S., D’Hondt, L., André, M., Holemans, X., & Canon, J. L. (2004) · Acta Clinica Belgica · doi:10.1179/acb.2004.032 · Cited by 36
Zein, E., Karaa, S. E., Chemaly, A., Saidi, I., Daou-Chahine, W., & Rohban, R. (2008) · PubMed · doi:10.1684/abc.2008.0210 · Cited by 33
Probiotic Use and Prevalence of Candidemia and Candiduria in a PICU
Kumar, S., Singhi, S. C., Chakrabarti, A., Bansal, A., & Jayashree, M. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31829f5d88 · Cited by 33
Wallace, T. C., & MacKay, D. (2011) · Journal of Nutrition · doi:10.3945/jn.111.147629 · Cited by 23
A Pain in the Neck: Probiotics for Ulcerative Colitis
Conen, A., Zimmerer, S., Trampuz, A., Frei, R., Battegay, M., & Elzi, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-12-200912150-00020 · Cited by 21
Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida
Lungarotti, M. S., Mezzetti, D., & Radicioni, M. (2003) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.88.5.f446 · Cited by 20
Dessart, S. R., & Steenson, L. R. (1991) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(91)78474-9 · Cited by 15
Piechno, S., Séguin, P., & Gangneux, J. (2007) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022650 · Cited by 14
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Postbiotics: An Evolving Term within the Functional Foods Field
Aguilar-Toalá, J. E., Garcia-Varela, R., Garcia, H. S., Mata-Haro, V., González-Córdova, A. F., Vallejo-Cordoba, B., & Hernández-Mendoza, A. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.03.009 · Cited by 1,078
Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives
Elshaghabee, F. M. F., Rokana, N., Gulhane, R. D., Sharma, C., & Panwar, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01490 · Cited by 940
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview
Piqué, N., Berlanga, M., & Miñana-Galbis, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102534 · Cited by 642
A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics
Mutua, V., & Gershwin, L. J. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08804-7 · Cited by 639
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.